GPC3 and breast neoplasm: Wnt-signaling pathway: LM3 breast tumor cells, when overexpressing GPC3, can secrete GPC3 to competitively interact with Wnt ligands, thereby preventing their binding to the Wnt receptor and consequently curbing the canonical Wnt-signaling pathway [109].